Filterlex wraps up FIH study for CAPTIS full-body embolic protection device
The study was designed to analyse the safety and feasibility of the CAPTIS device in patients undergoing Transcatheter…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 May 22
The study was designed to analyse the safety and feasibility of the CAPTIS device in patients undergoing Transcatheter…
11 May 22
The device delivers CCM therapy to the heart by sending timed electrical pulses to the heart, allowing more…
04 May 22
KardiaComplete is an enterprise solution for employers, health insurance plans and health systems to improve heart health and…
02 May 22
In the study, 89% of patients treated with the company’s TactiCath SE for persistent AFib experienced no symptoms…
02 May 22
The double-blind, randomised, controlled Safe and Timely Antithrombotic Removal-Direct Oral Anticoagulants (STAR-D) clinical trial is expected to enrol…
02 May 22
Xcardia Innovation Ltd. is a private medical device company developing innovative cardiovascular technologies
29 Apr 22
The trial will compare the efficiency and efficacy of image-guided ventricular tachycardia (VT) ablation versus traditional, catheter-based techniques…
27 Apr 22
Impella BTR is a forward flow heart pump designed to be implanted through the axillary artery and placed…
27 Apr 22
For the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust…
26 Apr 22
The UltraNav device is a dual-lumen catheter that enables side-by-side, simultaneous delivery of both ICE and transseptal needles…